Clinical Trial Update: Dapagliflozin in Non-diabetic Stage IV CKD [Phase 2]

View source ↗

Summary

Phase 2 trial update of dapagliflozin in non-diabetic stage IV chronic kidney disease; the study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Chronic Kidney Diseases | Phase 2 | Status: COMPLETED